Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Letter to the Editor Regarding...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Letter to the Editor Regarding: A Comprehensive Review on Copemyl®

Letter to the Editor Regarding: A Comprehensive Review on Copemyl®

Bibliographic Details
Main Authors: Giancarlo Comi, Ferdinando Nicoletti, Pier Luigi Canonico, Diego Centonze
Format: Article
Language:English
Published: Adis, Springer Healthcare 2018-11-01
Series:Neurology and Therapy
Subjects:
Equivalence
Follow-on glatiramer acetate
Glatiramer acetate
Multiple sclerosis
Online Access:http://link.springer.com/article/10.1007/s40120-018-0115-y
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://link.springer.com/article/10.1007/s40120-018-0115-y

Similar Items

  • Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl®
    by: Pietro Annovazzi, et al.
    Published: (2018-11-01)
  • Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue—Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers
    by: Oliver Neuhaus, et al.
    Published: (2021-03-01)
  • Tolerability, adverse events and compliance to glatiramer acetate in 28 patients with multiple sclerosis using the drug continuously for at least six months Tolerabilidade, eventos adversos e aderência ao acetato de glatiramer em 28 pacientes com esclerose múltipla usando a droga continuamente por pelo menos seis meses
    by: Ana Patricia Perez Fiore, et al.
    Published: (2005-09-01)
  • Glatiramer acetate 40 mg/ml: A review of the results of GALA and GLACIER clinical studies
    by: N. Yu. Lashch, et al.
    Published: (2016-07-01)
  • Non-biological complex drugs and their analogues in the pathogenetic therapy of multiple sclerosis: Issues of efficacy and safety in clinical use
    by: I. D. Stolyarov, et al.
    Published: (2015-03-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...